AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2017
Dec 1, 2017
29777_dirs_2017-12-01_a21807a8-44e7-4361-8475-f6f3ebcba1dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-11-30
Reporting Person: Bracken Sharon J (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-30 | Common shares without par value | S | 1588 | $56.121 | Disposed | 25618 | Direct |
| 2017-11-30 | Common shares without par value | S | 600 | $56.125 | Disposed | 25018 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 743 | Indirect |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of November 30, 2017.
More from ABBOTT LABORATORIES
Registration Form
2026
Apr 24
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25
Registration Form
2026
Mar 23
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4